Schedule: Monday - Saturday - 0:00 - 0:00, Sunday - 0:00 - 0:00

Conference Presentations

ACUTE LYMPHOBLASTIC LEUKEMIA

Topic: Recent advances in ALL
Presenter: Dr. Charles Mullighan
Institute: St. Jude Children's Research Hospital, Memphis, U.S
Topic: Understanding ETP-ALL - Biology and its implications
Presenter: Dr. Manju Sengar
Institute: Tata Memorial Centre, Mumbai, India
Topic: Management of AYA - which way to go?
Presenter: Dr. Prashant Ganesan
Institute: Regional Cancer Center, Jawaharlal Institute Of Postgraduate Medical Education & Research (JIPMER), Puducherry, India

ACUTE MYELOID LEUKEMIA

Topic: Recent advances in biology of AML
Presenter: Dr.Harry Erba
Institute: Duke Cancer Institute, Durham, U.S
Topic: Evolving landscape of de-novo AML therapy
Presenter: Dr. Farhad Ravandi
Institute: MD Anderson Cancer Centre, Huston, U.S
Topic: Approach to elderly Acute Myeloid Leukemia
Presenter: Dr. Harry Erba
Institute: Duke Cancer Institute, Durham, U.S

ACUTE PROMYELOCYTIC LEUKEMIA

Topic: Acute Promyelocytic Leukemia: Current understanding of biology and management
Presenter: Harry Iland
Institute: Royal Prince Alfred Hospital,Sydney, Australia

MULTIPLE MYELOMA

Topic: Recent advances in the of Multiple Myeloma
Presenter: Dr. Sundar Jagannath
Institute: The Mount Sinai Hospital,New York, U.S
Topic: How to treat newly diagnosed multiple myeloma
Presenter: Dr. Anoop Devasia
Institute: Christian Medical College (CMC), Vellore,India

CHRONIC MYELOID LEUKEMIA

Topic: Consensus and controversies in front-line therapy of CML
Presenter: Dr. Timothy Hughes
Institute: SAHMRI, Adelaide, South Australia
Topic: Toxicities of TKI: Compare and contrast
Presenter: Dr. Dinesh Bhurani
Institute: Rajiv Gandhi Cancer Institute And Research Centre, New Delhi, India
Topic: Treatment free remission- is it ready for clinics
Presenter: Dr. Timothy Hughes
Institute: SAHMRI, Adelaide, South Australia

MYELODYSPLASTIC SYNDROME

Topic: MDS: Management of Low risk MDS
Presenter: Dr. Jina Bhattacharya
Institute: Gauhati Medical College and Hospital, Guwahati, India
Topic: Management of high-risk MDS and secondary AML
Presenter: Dr. Austin Kulasekaraj
Institute: King's College Hospital NHS Foundation Trust, London, UK

MRD / RECENT ADVANCES IN HEMATOLOGY

Topic: MRD in ALL: Current status and recent advances
Presenter: Dr. Charles Mullighan
Institute: St. Jude Children's Research Hospital, Memphis, U.S
Topic: Role of next generation sequencing in myeloid malignancies: Laboratory perspective
Presenter: Dr. Nikhil Patkar
Institute: Tata Memorial Centre, Mumbai, India
Topic: Role of next generation sequencing in myeloid malignancies: Clinicians perspective
Presenter: Dr. Harry Erba
Institute: Duke Cancer Institute, Durham, U.S
Topic: MRD in Myeloma: Laboratory perspective
Presenter: Dr. Prashant Tembhare
Institute: Tata Memorial Centre, Mumbai, India
Topic: MRD in Myeloma: Clinicians perspective
Presenter: Dr. Sundar Jagannath
Institute: The Mount Sinai Hospital, New York, U.S

BREAKTHROUGH AND RECENTLY APPROVED DRUGS

Topic: Bcl2 inhibitors and hematology
Presenter: Dr. Atul Sharma
Institute: All India Institute of Medical Sciences (AIIMS), New Delhi
Topic: Antibody based immunotherapy in hematology
Presenter: Dr. Reetu Jain
Institute: Jaslok Hospital and Research center, Mumbai, India